Insider Shareholders with Direct Ownership of Cv Rx, Inc. (CVRX)
This section provides a comprehensive overview of the insiders with direct ownership of Cv Rx, Inc. (CVRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CVRx, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Enterprise Associates 10 L P New
> 10% Shareholder |
2,026,083 | 0 | 2,026,083 $22.8 Million | 1 |
Jul 02, 2021
Added 10.02%
|
|
Kevin Hykes
PRES & CEO |
128,000 | 0 | 128,000 $1.44 Million | 2 |
Feb 28, 2025
Added 43.36%
|
|
Robert Allen John
Chief Revenue Officer |
55,000 | 0 | 55,000 $618,200 | 1 |
Feb 28, 2025
Added 50.0%
|
|
Dean Bruhn Ding
VP OF REG. AFFAIRS AND QA |
49,000 | 0 | 54,648 $614,243 | 2 |
Feb 08, 2022
Added 8.62%
|
|
Jared Oasheim
CHIEF FINANCIAL OFFICER |
37,447 | 0 | 37,447 $420,904 | 3 |
Feb 28, 2025
Added 37.01%
|
| 30,645 | 0 | 30,645 $344,449 | 7 |
Aug 15, 2024
Added 8.92%
|
|
| 27,777 | 0 | 28,266 $317,709 | 1 |
Jul 02, 2021
Added 49.56%
|
|
|
Nadim Yared
CHIEF EXECUTIVE OFFICER |
43,835 | 17,580 | 26,255 $295,106 | 7 |
Jan 29, 2024
Added 6.9%
|
|
John Brintnall
CHIEF STRATEGY OFFICER AND SEC |
21,901 | 0 | 21,901 $246,167 | 3 |
Apr 22, 2022
Added 5.46%
|
|
Philip B. Adamson
Chief Medical Officer |
20,000 | 0 | 20,000 $224,800 | 1 |
Feb 28, 2025
Added 50.0%
|
|
Paul Verrastro
CHIEF MKTG & STRAT OFFICER |
36,250 | 19,415 | 16,835 $189,225 | 14 |
Feb 28, 2025
Added 48.73%
|
| 3,400 | 0 | 3,400 $38,216 | 5 |
Feb 28, 2022
Added 15.0%
|
|
|
Craig E. Palmer
SVP, U.S. SALES |
1,229 | 0 | 1,229 $13,813 | 2 |
Mar 25, 2024
Added 10.94%
|
|
Liz Galle
VP OF GLOBAL CLINICAL RESEARCH |
778 | 0 | 778 $8,744 | 1 |
Oct 16, 2023
Added 50.0%
|
| 316 | 0 | 316 $3,551 | 1 |
Dec 14, 2023
Added 50.0%
|
|
|
Johnson & Johnson Innovation Jjdc, Inc.
> 10% Shareholder |
0 | 3,495,575 | 0 $0 | 1 |
Sep 15, 2023
Reduced 100.0%
|